Suppr超能文献

发育和病理过程中的脑 angiogenesis:脑肿瘤的机制与治疗干预

Brain angiogenesis in developmental and pathological processes: mechanism and therapeutic intervention in brain tumors.

作者信息

Kim Woo-Young, Lee Ho-Young

机构信息

Department of Thoracic/Head and Neck Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.

出版信息

FEBS J. 2009 Sep;276(17):4653-64. doi: 10.1111/j.1742-4658.2009.07177.x. Epub 2009 Jul 31.

Abstract

Formation of new blood vessels is required for the growth and metastasis of all solid tumors. New blood vessels are established in tumors mainly through angiogenesis. Brain tumors in particular are highly angiogenic. Therefore, interventions designed to prevent angiogenesis may be effective at controlling brain tumors. Indeed, many recent findings from preclinical and clinical studies of antiangiogenic therapy for brain tumors have shown that it is a promising approach to managing this deadly disease, especially when combined with other cytotoxic treatments. In this minireview, we summarize the basic characteristics of brain tumor angiogenesis and the role of known angiogenic factors in regulating this angiogenesis, which may be targets of antiangiogenic therapy. We also discuss the current status of antiangiogenic therapy for brain tumors, the suggested mechanisms of this therapy and the limitations of this strategy.

摘要

所有实体瘤的生长和转移都需要新血管的形成。肿瘤中的新血管主要通过血管生成来建立。特别是脑肿瘤具有高度的血管生成能力。因此,旨在预防血管生成的干预措施可能对控制脑肿瘤有效。事实上,最近许多关于脑肿瘤抗血管生成治疗的临床前和临床研究结果表明,这是治疗这种致命疾病的一种有前景的方法,尤其是与其他细胞毒性治疗联合使用时。在本综述中,我们总结了脑肿瘤血管生成的基本特征以及已知血管生成因子在调节这种血管生成中的作用,这些可能是抗血管生成治疗的靶点。我们还讨论了脑肿瘤抗血管生成治疗的现状、该治疗的推测机制以及该策略的局限性。

相似文献

5
Antiangiogenic therapy in brain tumors.脑肿瘤的抗血管生成治疗
Expert Rev Neurother. 2008 Oct;8(10):1457-73. doi: 10.1586/14737175.8.10.1457.
6
Antiangiogenic therapy for primary and metastatic brain tumors.原发性和转移性脑肿瘤的抗血管生成治疗
Hematol Oncol Clin North Am. 2004 Oct;18(5):1161-81, x. doi: 10.1016/j.hoc.2004.05.003.
7
Inhibition of angiogenesis as a therapeutic strategy against brain tumors.
Cancer Treat Res. 2004;117:307-36. doi: 10.1007/978-1-4419-8871-3_18.
8
Inhibition of angiogenesis and invasion in malignant gliomas.恶性胶质瘤中血管生成和侵袭的抑制
Expert Rev Anticancer Ther. 2007 Nov;7(11):1537-60. doi: 10.1586/14737140.7.11.1537.
10
Anti-angiogenic agents for the treatment of brain tumors.
Neuroimaging Clin N Am. 2002 Nov;12(4):477-99. doi: 10.1016/s1052-5149(02)00035-7.

引用本文的文献

4
Therapeutic Options in Neuro-Oncology.神经肿瘤学的治疗选择。
Int J Mol Sci. 2022 May 11;23(10):5351. doi: 10.3390/ijms23105351.

本文引用的文献

1
The roles of chemokine CXCL12 in embryonic and brain tumor angiogenesis.趋化因子CXCL12在胚胎及脑肿瘤血管生成中的作用。
Semin Cancer Biol. 2009 Apr;19(2):111-5. doi: 10.1016/j.semcancer.2008.11.001. Epub 2008 Nov 7.
2
Malignant gliomas in adults.成人恶性胶质瘤
N Engl J Med. 2008 Oct 23;359(17):1850; author reply 1850. doi: 10.1056/NEJMc086380.
3
Modes of resistance to anti-angiogenic therapy.抗血管生成疗法的耐药模式。
Nat Rev Cancer. 2008 Aug;8(8):592-603. doi: 10.1038/nrc2442.
5
gamma-Secretase: a multifaceted regulator of angiogenesis.γ-分泌酶:血管生成的多面调节因子。
J Cell Mol Med. 2008 Jun;12(3):781-95. doi: 10.1111/j.1582-4934.2008.00274.x. Epub 2008 Feb 8.
6
Gamma-secretase regulates VEGFR-1 signalling in vascular endothelium and RPE.
Adv Exp Med Biol. 2008;613:313-9. doi: 10.1007/978-0-387-74904-4_36.
9
Nerve growth factor as an angiogenic factor.神经生长因子作为一种血管生成因子。
Microvasc Res. 2008 Mar;75(2):135-41. doi: 10.1016/j.mvr.2007.07.004. Epub 2007 Jul 21.
10
Notch and cancer: a double-edged sword.Notch与癌症:一把双刃剑。
Cell Mol Life Sci. 2007 Nov;64(21):2746-62. doi: 10.1007/s00018-007-7164-1.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验